Oct 2026
Comparative effectiveness and safety of rituximab versus ocrelizumab in relapsing-remitting multiple sclerosis: a real-world experience from Iran.
Fatemeh Meshkini, Nahid Beladi Moghaddam, Mehran Ghaffari et al.
· Acta Neurologica Belgica · 0 citations